Literature DB >> 5356984

Fibrin-fibrinogen degradation products in sera of normal infants and children.

W S Uttley, A G Allan, J D Cash.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5356984      PMCID： PMC2020358          DOI： 10.1136/adc.44.238.761

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  25 in total

1.  STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.

Authors:  E KOWALSKI; A Z BUDZYNSKI; M KOPEC; Z S LATALLO; B LIPINSKI; Z WEGRZYNOWICZ
Journal:  Thromb Diath Haemorrh       Date:  1964-10-15

2.  Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Clin Invest       Date:  1962-04       Impact factor: 14.808

3.  Coagulation changes in the neonatal period and in early infancy.

Authors:  A J ABALLI; S DE LAMERENS
Journal:  Pediatr Clin North Am       Date:  1962-08       Impact factor: 3.278

4.  The biological significance of fibrinolysis.

Authors:  T ASTRUP
Journal:  Lancet       Date:  1956-09-15       Impact factor: 79.321

5.  Epidemic gastroenteritis due to Escherichia coli O111 B4. II. Pathologic anatomy, with special reference of the presence of the local and generalized Shwartzman phenomena.

Authors:  D G MCKAY; G H WAHLE
Journal:  AMA Arch Pathol       Date:  1955-12

6.  In vitro and in vivo studies with trasylol, an anticoagulant and a fibrinolytic inhibitor.

Authors:  A H Dubber; G P McNicol; D Uttley; A S Douglas
Journal:  Br J Haematol       Date:  1968-01       Impact factor: 6.998

7.  Intravascular coagulation and hyaline-membrane disease of the newborn.

Authors:  C R Stark; D Abramson; V Erkan
Journal:  Lancet       Date:  1968-06-01       Impact factor: 79.321

8.  Disseminated fibrin thromboembolism among neonates dying within 48 hours of birth.

Authors:  J F Boyd
Journal:  Arch Dis Child       Date:  1967-08       Impact factor: 3.791

9.  Demonstration of split products of fibrinogen in the blood of normal newborns.

Authors:  E Bonifaci; P Baggio; E Gravina
Journal:  Biol Neonat       Date:  1968

10.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113
View more
  4 in total

1.  Fibrin-fibrinogen degradation products in children with renal disease.

Authors:  W S Uttley; H Maxwell; J D Cash
Journal:  Arch Dis Child       Date:  1974-02       Impact factor: 3.791

2.  Incidence of disseminated intravascular coagulation in the course of septicemia in newborn infants.

Authors:  M Alebouyeh; A Remien; W Marget
Journal:  Z Kinderheilkd       Date:  1971

3.  Serum levels of fibrin-fibrinogen degradation products in the haemolytic-uraemic syndrome.

Authors:  W S Uttley
Journal:  Arch Dis Child       Date:  1970-08       Impact factor: 3.791

4.  Serum fibrin-fibrinogen degradation products associated with postoperative pulmonary embolus and venous thrombosis.

Authors:  C V Ruckley; P C Das; A G Leitch; A A Donaldson; W A Copland; A T Redpath; P Scott; J D Cash
Journal:  Br Med J       Date:  1970-11-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.